10/15/2024 7:30:32 AM DLA Piper Genomics Series: From crisp packets to CRISPR, and beyond By Rebecca Lawrence Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
8/14/2024 3:50:44 PM Drug discovery and development in the age of AI By Rebecca Lawrence DLA Piper’s inaugural Life Sciences Index is a survey and study series about perceptions of innovation and growth in the life sciences...
6/28/2024 12:58:42 PM The evolving landscape of patent term extensions By Rebecca Lawrence Petros Nafpliotis Part 1: Supplementary Protection Certificates – harmonisation Following the European elections earlier this month, innovator’s eyes are...
2/5/2024 8:18:08 PM A patent perspective on the battle against cancer By Rebecca Lawrence 4 February is World Cancer Day, an international day marked to raise awareness of cancer and to encourage its prevention, detection, and...
12/13/2023 4:18:54 PM Experimental evidence in patent litigation – Rules for fair play By Rebecca Lawrence The technical nature of patent litigation means that experiments are often an essential (and sometimes the only) way to prove key aspects...
9/28/2023 3:42:15 PM Regulation and patentability of NGT plants – what’s next for the UK? By Rebecca Lawrence Dharma Carlin EU Commission Proposal On 5 July 2023, the European Commission proposed a new legislative initiative regarding plants obtained by...
8/30/2023 2:44:34 PM Bifurcation before the UPC – who filed it first? By Rebecca Lawrence Mary Foord-Weston The Unified Patent Court (UPC) launched on 1 June 2023 and has the power to determine infringement and validity of new Unitary Patents...